| 1 | [SID99360663] | Active | IC50 | 3.69 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 3.69 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 2 | [SID99360663] | Active | IC50 | 3.69 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 3.69 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 3 | [SID99360663] | Active | IC50 | 3.69 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 3.69 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 4 | [SID99360663] | Active | IC50 | 4.48 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 4.48 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 5 | [SID99360663] | Active | IC50 | 4.48 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 4.48 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 6 | [SID99360663] | Active | IC50 | 4.48 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen [AID624347, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 4.48 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen | | AID | 624347 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 7 | [SID99360663] | Active | IC50 | 9.52 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 9.52 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 8 | [SID99360663] | Active | IC50 | 9.52 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | 9.52 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 9 | [SID99360663] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 10 | [SID99360663] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 11 | [SID99360663] | Active | | | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective Ga16 antagonists [AID651952, Type: screening] | GNA15 gene product [Homo sapiens] [gi:156104883] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput screening assay to identify nonselective Ga16 antagonists | | AID | 651952 | | BioAssay type | screening | | Target | GNA15 gene product [Homo sapiens] [gi:156104883] | | PubMed | | | Data Table |  |
|
| 12 | [SID136650] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain [AID161, Type: other] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain | | AID | 161 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID136650] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain [AID157, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain | | AID | 157 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID136650] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain [AID155, Type: other] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the rad50 strain | | AID | 155 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID136650] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain [AID165, Type: other] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain | | AID | 165 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID136650] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain [AID167, Type: other] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the bub3 strain | | AID | 167 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID136650] | Active | | | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain [AID175, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Active | | BioAssay | NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain | | AID | 175 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID99360663] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 19 | [SID99360663] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 20 | [SID99360663] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 21 | [SID99360663] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 22 | [SID99360663] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 23 | [SID99360663] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 24 | [SID99360663] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID651783, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651783 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 25 | [SID99360663] | Active | | | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID651783, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput confirmation assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 651783 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 26 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_2, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 27 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_2, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 28 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_3, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 29 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_3, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 30 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_5, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 31 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_5, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 32 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_6, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 33 | [SID99360663] | Unspecified | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_6, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Unspecified | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 34 | [SID99360663] | Inactive | Potency | 35.4813 | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen [AID588856, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of TGF-b: Cytotox Counterscreen | | AID | 588856 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID99360663] | Inactive | Potency | 50.1187 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 36 | [SID99360663] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 37 | [SID99360663] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 38 | [SID99360663] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 39 | [SID99360663] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 40 | [SID99360663] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 41 | [SID99360663] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 42 | [SID99360663] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 43 | [SID99360663] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 44 | [SID99360663] | Inactive | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_4, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 45 | [SID99360663] | Inactive | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_4, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 46 | [SID136650] | Inactive | | | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice [AID330, Type: other] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 136650 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | NCI In Vivo Anticancer Drug Screen. Data for tumor model P388 Leukemia (intraperitoneal) in CD2F1 (CDF1) mice | | AID | 330 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID26540935] | Inactive | | | Luminescence-based counterscreen for inhibitors of NADPH oxidase 1 (Nox1): biochemical high throughput screening assay to identify inhibitors of luminol (Maybridge Library) [AID1823, Type: screening] | |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26540935 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | Luminescence-based counterscreen for inhibitors of NADPH oxidase 1 (Nox1): biochemical high throughput screening assay to identify inhibitors of luminol (Maybridge Library) | | AID | 1823 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 48 | [SID99360663] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID99360663] | Inactive | | | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts [AID588335, Type: screening] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts | | AID | 588335 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID99360663] | Inactive | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 99360663 | | CID | 2803133 | | Outcome | Inactive | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|